© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Matthew Fowler
Articles
SGX301 Demonstrates Positive Benefits for Cutaneous T-Cell Lymphoma
October 22, 2020
Cycle 3 of the FLASH study reported that patients taking SGX301 to treat cutaneous t-cell lymphoma saw improved responses and maintained a positive safety profile.
Study Analyzing Daratumumab to Treat Patients with Multiple Myeloma Induces Positive Topline Results
October 22, 2020
Genmab recently announced positive topline results from part 2 of the Phase 3 CASSIOPEIA study examining daratumumab monotherapy as maintenance therapy to treat patients diagnosed with multiple myeloma.
Breast Cancer Incidence Rates Increase for Racial/Ethnic and Age Groups Between 2010 to 2016
October 19, 2020
A recent examination of breast cancer subtypes, specifically luminal A and luminal B breast cancer, found that incidence rates from 2010-2016 increased for a number of racial/ethnic and age groups.
Two Studies Examining Pembrolizumab Combinations Induce Positive Outcomes in Advanced NSCLC
October 19, 2020
Merck announced positive data regarding 2 studies, one examining pembrolizumab in combination with chemotherapy and another in combination with quavonlimab in combination to treat advanced non-small cell lung cancer.